Report Detail
Global Antibody Based Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029
- RnM4567000 |
- 24 November, 2023 |
- Global |
- 128 Pages |
- GIR (Global Info Research) |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Antibody Based Therapeutics market size was valued at USD 180490 million in 2022 and is forecast to a readjusted size of USD 363690 million by 2029 with a CAGR of 10.5% during review period.
Therapeutic antibodies are drugs that use antibodies, one of the main players in our immune system inherent in our body. By making use of the specificity by which each antibody recognizes only one antigen, pinpointed attacks on specific antigens are possible.
The Therapeutic Antibodies Drug Market is driven by the remarkable potential of therapeutic antibodies to treat a diverse array of diseases, from cancer and autoimmune disorders to infectious diseases. Monoclonal antibodies have gained prominence as highly targeted and effective therapeutic agents that can modulate the immune system, neutralize pathogens, and inhibit disease-associated proteins. As precision medicine and biopharmaceutical innovations continue to advance, the demand for therapeutic antibodies grows. Innovations in antibody design, engineering, and manufacturing technologies further contribute to market expansion. Nevertheless, a significant challenge for this market is the need to address high production costs, optimize therapeutic antibody development processes, and navigate complex regulatory pathways while ensuring accessibility and affordability for patients. Overcoming manufacturing complexities, managing research and development costs, and addressing regulatory standards are ongoing challenges. Additionally, the market faces competition from small molecules and other biologic therapies, necessitating continuous research and development efforts to unlock the full therapeutic potential of therapeutic antibodies. Striking a balance between providing safe, effective, and accessible therapeutic antibody drugs while addressing scientific and regulatory challenges is essential for the continued growth of the Therapeutic Antibodies Drug Market.
The Global Info Research report includes an overview of the development of the Antibody Based Therapeutics industry chain, the market status of Immune Diseases (Monoclonal Antibodies, Bi-Specific Antibodies Therapy), Cancer (Monoclonal Antibodies, Bi-Specific Antibodies Therapy), and key enterprises in developed and developing market, and analysed the cutting-edge technology, patent, hot applications and market trends of Antibody Based Therapeutics.
Regionally, the report analyzes the Antibody Based Therapeutics markets in key regions. North America and Europe are experiencing steady growth, driven by government initiatives and increasing consumer awareness. Asia-Pacific, particularly China, leads the global Antibody Based Therapeutics market, with robust domestic demand, supportive policies, and a strong manufacturing base.
Key Features:
The report presents comprehensive understanding of the Antibody Based Therapeutics market. It provides a holistic view of the industry, as well as detailed insights into individual components and stakeholders. The report analysis market dynamics, trends, challenges, and opportunities within the Antibody Based Therapeutics industry.
The report involves analyzing the market at a macro level:
Market Sizing and Segmentation: Report collect data on the overall market size, including the revenue generated, and market share of different by Type (e.g., Monoclonal Antibodies, Bi-Specific Antibodies Therapy).
Industry Analysis: Report analyse the broader industry trends, such as government policies and regulations, technological advancements, consumer preferences, and market dynamics. This analysis helps in understanding the key drivers and challenges influencing the Antibody Based Therapeutics market.
Regional Analysis: The report involves examining the Antibody Based Therapeutics market at a regional or national level. Report analyses regional factors such as government incentives, infrastructure development, economic conditions, and consumer behaviour to identify variations and opportunities within different markets.
Market Projections: Report covers the gathered data and analysis to make future projections and forecasts for the Antibody Based Therapeutics market. This may include estimating market growth rates, predicting market demand, and identifying emerging trends.
The report also involves a more granular approach to Antibody Based Therapeutics:
Company Analysis: Report covers individual Antibody Based Therapeutics players, suppliers, and other relevant industry players. This analysis includes studying their financial performance, market positioning, product portfolios, partnerships, and strategies.
Consumer Analysis: Report covers data on consumer behaviour, preferences, and attitudes towards Antibody Based Therapeutics This may involve surveys, interviews, and analysis of consumer reviews and feedback from different by Application (Immune Diseases, Cancer).
Technology Analysis: Report covers specific technologies relevant to Antibody Based Therapeutics. It assesses the current state, advancements, and potential future developments in Antibody Based Therapeutics areas.
Competitive Landscape: By analyzing individual companies, suppliers, and consumers, the report present insights into the competitive landscape of the Antibody Based Therapeutics market. This analysis helps understand market share, competitive advantages, and potential areas for differentiation among industry players.
Market Validation: The report involves validating findings and projections through primary research, such as surveys, interviews, and focus groups.
Market Segmentation
Antibody Based Therapeutics market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.
Market segment by Type
Monoclonal Antibodies
Bi-Specific Antibodies Therapy
Antibody-drug Conjugates
Other
Market segment by Application
Immune Diseases
Cancer
Other
Market segment by players, this report covers
AbbVie
Johnson & Johnson
Novartis
Gilead Sciences
Roche
Bristol-Myers Squibb
Amgen
AstraZeneca
Merck & Co
Takeda
Merck KGaA
Seagen
Eli Lilly
Ono Pharmaceutical
Pfizer
Regeneron
Innovent
Hengrui Medicine
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
South America (Brazil, Argentina and Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Antibody Based Therapeutics product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Antibody Based Therapeutics, with revenue, gross margin and global market share of Antibody Based Therapeutics from 2018 to 2023.
Chapter 3, the Antibody Based Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Antibody Based Therapeutics market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends and Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Antibody Based Therapeutics.
Chapter 13, to describe Antibody Based Therapeutics research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope of Antibody Based Therapeutics
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Classification of Antibody Based Therapeutics by Type
- 1.3.1 Overview: Global Antibody Based Therapeutics Market Size by Type: 2018 Versus 2022 Versus 2029
- 1.3.2 Global Antibody Based Therapeutics Consumption Value Market Share by Type in 2022
- 1.3.3 Monoclonal Antibodies
- 1.3.4 Bi-Specific Antibodies Therapy
- 1.3.5 Antibody-drug Conjugates
- 1.3.6 Other
- 1.4 Global Antibody Based Therapeutics Market by Application
- 1.4.1 Overview: Global Antibody Based Therapeutics Market Size by Application: 2018 Versus 2022 Versus 2029
- 1.4.2 Immune Diseases
- 1.4.3 Cancer
- 1.4.4 Other
- 1.5 Global Antibody Based Therapeutics Market Size & Forecast
- 1.6 Global Antibody Based Therapeutics Market Size and Forecast by Region
- 1.6.1 Global Antibody Based Therapeutics Market Size by Region: 2018 VS 2022 VS 2029
- 1.6.2 Global Antibody Based Therapeutics Market Size by Region, (2018-2029)
- 1.6.3 North America Antibody Based Therapeutics Market Size and Prospect (2018-2029)
- 1.6.4 Europe Antibody Based Therapeutics Market Size and Prospect (2018-2029)
- 1.6.5 Asia-Pacific Antibody Based Therapeutics Market Size and Prospect (2018-2029)
- 1.6.6 South America Antibody Based Therapeutics Market Size and Prospect (2018-2029)
- 1.6.7 Middle East and Africa Antibody Based Therapeutics Market Size and Prospect (2018-2029)
2 Company Profiles
- 2.1 AbbVie
- 2.1.1 AbbVie Details
- 2.1.2 AbbVie Major Business
- 2.1.3 AbbVie Antibody Based Therapeutics Product and Solutions
- 2.1.4 AbbVie Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.1.5 AbbVie Recent Developments and Future Plans
- 2.2 Johnson & Johnson
- 2.2.1 Johnson & Johnson Details
- 2.2.2 Johnson & Johnson Major Business
- 2.2.3 Johnson & Johnson Antibody Based Therapeutics Product and Solutions
- 2.2.4 Johnson & Johnson Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.2.5 Johnson & Johnson Recent Developments and Future Plans
- 2.3 Novartis
- 2.3.1 Novartis Details
- 2.3.2 Novartis Major Business
- 2.3.3 Novartis Antibody Based Therapeutics Product and Solutions
- 2.3.4 Novartis Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.3.5 Novartis Recent Developments and Future Plans
- 2.4 Gilead Sciences
- 2.4.1 Gilead Sciences Details
- 2.4.2 Gilead Sciences Major Business
- 2.4.3 Gilead Sciences Antibody Based Therapeutics Product and Solutions
- 2.4.4 Gilead Sciences Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.4.5 Gilead Sciences Recent Developments and Future Plans
- 2.5 Roche
- 2.5.1 Roche Details
- 2.5.2 Roche Major Business
- 2.5.3 Roche Antibody Based Therapeutics Product and Solutions
- 2.5.4 Roche Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.5.5 Roche Recent Developments and Future Plans
- 2.6 Bristol-Myers Squibb
- 2.6.1 Bristol-Myers Squibb Details
- 2.6.2 Bristol-Myers Squibb Major Business
- 2.6.3 Bristol-Myers Squibb Antibody Based Therapeutics Product and Solutions
- 2.6.4 Bristol-Myers Squibb Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.6.5 Bristol-Myers Squibb Recent Developments and Future Plans
- 2.7 Amgen
- 2.7.1 Amgen Details
- 2.7.2 Amgen Major Business
- 2.7.3 Amgen Antibody Based Therapeutics Product and Solutions
- 2.7.4 Amgen Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.7.5 Amgen Recent Developments and Future Plans
- 2.8 AstraZeneca
- 2.8.1 AstraZeneca Details
- 2.8.2 AstraZeneca Major Business
- 2.8.3 AstraZeneca Antibody Based Therapeutics Product and Solutions
- 2.8.4 AstraZeneca Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.8.5 AstraZeneca Recent Developments and Future Plans
- 2.9 Merck & Co
- 2.9.1 Merck & Co Details
- 2.9.2 Merck & Co Major Business
- 2.9.3 Merck & Co Antibody Based Therapeutics Product and Solutions
- 2.9.4 Merck & Co Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.9.5 Merck & Co Recent Developments and Future Plans
- 2.10 Takeda
- 2.10.1 Takeda Details
- 2.10.2 Takeda Major Business
- 2.10.3 Takeda Antibody Based Therapeutics Product and Solutions
- 2.10.4 Takeda Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.10.5 Takeda Recent Developments and Future Plans
- 2.11 Merck KGaA
- 2.11.1 Merck KGaA Details
- 2.11.2 Merck KGaA Major Business
- 2.11.3 Merck KGaA Antibody Based Therapeutics Product and Solutions
- 2.11.4 Merck KGaA Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.11.5 Merck KGaA Recent Developments and Future Plans
- 2.12 Seagen
- 2.12.1 Seagen Details
- 2.12.2 Seagen Major Business
- 2.12.3 Seagen Antibody Based Therapeutics Product and Solutions
- 2.12.4 Seagen Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.12.5 Seagen Recent Developments and Future Plans
- 2.13 Eli Lilly
- 2.13.1 Eli Lilly Details
- 2.13.2 Eli Lilly Major Business
- 2.13.3 Eli Lilly Antibody Based Therapeutics Product and Solutions
- 2.13.4 Eli Lilly Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.13.5 Eli Lilly Recent Developments and Future Plans
- 2.14 Ono Pharmaceutical
- 2.14.1 Ono Pharmaceutical Details
- 2.14.2 Ono Pharmaceutical Major Business
- 2.14.3 Ono Pharmaceutical Antibody Based Therapeutics Product and Solutions
- 2.14.4 Ono Pharmaceutical Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.14.5 Ono Pharmaceutical Recent Developments and Future Plans
- 2.15 Pfizer
- 2.15.1 Pfizer Details
- 2.15.2 Pfizer Major Business
- 2.15.3 Pfizer Antibody Based Therapeutics Product and Solutions
- 2.15.4 Pfizer Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.15.5 Pfizer Recent Developments and Future Plans
- 2.16 Regeneron
- 2.16.1 Regeneron Details
- 2.16.2 Regeneron Major Business
- 2.16.3 Regeneron Antibody Based Therapeutics Product and Solutions
- 2.16.4 Regeneron Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.16.5 Regeneron Recent Developments and Future Plans
- 2.17 Innovent
- 2.17.1 Innovent Details
- 2.17.2 Innovent Major Business
- 2.17.3 Innovent Antibody Based Therapeutics Product and Solutions
- 2.17.4 Innovent Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.17.5 Innovent Recent Developments and Future Plans
- 2.18 Hengrui Medicine
- 2.18.1 Hengrui Medicine Details
- 2.18.2 Hengrui Medicine Major Business
- 2.18.3 Hengrui Medicine Antibody Based Therapeutics Product and Solutions
- 2.18.4 Hengrui Medicine Antibody Based Therapeutics Revenue, Gross Margin and Market Share (2018-2023)
- 2.18.5 Hengrui Medicine Recent Developments and Future Plans
3 Market Competition, by Players
- 3.1 Global Antibody Based Therapeutics Revenue and Share by Players (2018-2023)
- 3.2 Market Share Analysis (2022)
- 3.2.1 Market Share of Antibody Based Therapeutics by Company Revenue
- 3.2.2 Top 3 Antibody Based Therapeutics Players Market Share in 2022
- 3.2.3 Top 6 Antibody Based Therapeutics Players Market Share in 2022
- 3.3 Antibody Based Therapeutics Market: Overall Company Footprint Analysis
- 3.3.1 Antibody Based Therapeutics Market: Region Footprint
- 3.3.2 Antibody Based Therapeutics Market: Company Product Type Footprint
- 3.3.3 Antibody Based Therapeutics Market: Company Product Application Footprint
- 3.4 New Market Entrants and Barriers to Market Entry
- 3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
- 4.1 Global Antibody Based Therapeutics Consumption Value and Market Share by Type (2018-2023)
- 4.2 Global Antibody Based Therapeutics Market Forecast by Type (2024-2029)
5 Market Size Segment by Application
- 5.1 Global Antibody Based Therapeutics Consumption Value Market Share by Application (2018-2023)
- 5.2 Global Antibody Based Therapeutics Market Forecast by Application (2024-2029)
6 North America
- 6.1 North America Antibody Based Therapeutics Consumption Value by Type (2018-2029)
- 6.2 North America Antibody Based Therapeutics Consumption Value by Application (2018-2029)
- 6.3 North America Antibody Based Therapeutics Market Size by Country
- 6.3.1 North America Antibody Based Therapeutics Consumption Value by Country (2018-2029)
- 6.3.2 United States Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 6.3.3 Canada Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 6.3.4 Mexico Antibody Based Therapeutics Market Size and Forecast (2018-2029)
7 Europe
- 7.1 Europe Antibody Based Therapeutics Consumption Value by Type (2018-2029)
- 7.2 Europe Antibody Based Therapeutics Consumption Value by Application (2018-2029)
- 7.3 Europe Antibody Based Therapeutics Market Size by Country
- 7.3.1 Europe Antibody Based Therapeutics Consumption Value by Country (2018-2029)
- 7.3.2 Germany Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 7.3.3 France Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 7.3.4 United Kingdom Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 7.3.5 Russia Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 7.3.6 Italy Antibody Based Therapeutics Market Size and Forecast (2018-2029)
8 Asia-Pacific
- 8.1 Asia-Pacific Antibody Based Therapeutics Consumption Value by Type (2018-2029)
- 8.2 Asia-Pacific Antibody Based Therapeutics Consumption Value by Application (2018-2029)
- 8.3 Asia-Pacific Antibody Based Therapeutics Market Size by Region
- 8.3.1 Asia-Pacific Antibody Based Therapeutics Consumption Value by Region (2018-2029)
- 8.3.2 China Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 8.3.3 Japan Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 8.3.4 South Korea Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 8.3.5 India Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 8.3.6 Southeast Asia Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 8.3.7 Australia Antibody Based Therapeutics Market Size and Forecast (2018-2029)
9 South America
- 9.1 South America Antibody Based Therapeutics Consumption Value by Type (2018-2029)
- 9.2 South America Antibody Based Therapeutics Consumption Value by Application (2018-2029)
- 9.3 South America Antibody Based Therapeutics Market Size by Country
- 9.3.1 South America Antibody Based Therapeutics Consumption Value by Country (2018-2029)
- 9.3.2 Brazil Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 9.3.3 Argentina Antibody Based Therapeutics Market Size and Forecast (2018-2029)
10 Middle East & Africa
- 10.1 Middle East & Africa Antibody Based Therapeutics Consumption Value by Type (2018-2029)
- 10.2 Middle East & Africa Antibody Based Therapeutics Consumption Value by Application (2018-2029)
- 10.3 Middle East & Africa Antibody Based Therapeutics Market Size by Country
- 10.3.1 Middle East & Africa Antibody Based Therapeutics Consumption Value by Country (2018-2029)
- 10.3.2 Turkey Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 10.3.3 Saudi Arabia Antibody Based Therapeutics Market Size and Forecast (2018-2029)
- 10.3.4 UAE Antibody Based Therapeutics Market Size and Forecast (2018-2029)
11 Market Dynamics
- 11.1 Antibody Based Therapeutics Market Drivers
- 11.2 Antibody Based Therapeutics Market Restraints
- 11.3 Antibody Based Therapeutics Trends Analysis
- 11.4 Porters Five Forces Analysis
- 11.4.1 Threat of New Entrants
- 11.4.2 Bargaining Power of Suppliers
- 11.4.3 Bargaining Power of Buyers
- 11.4.4 Threat of Substitutes
- 11.4.5 Competitive Rivalry
12 Industry Chain Analysis
- 12.1 Antibody Based Therapeutics Industry Chain
- 12.2 Antibody Based Therapeutics Upstream Analysis
- 12.3 Antibody Based Therapeutics Midstream Analysis
- 12.4 Antibody Based Therapeutics Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
- 14.1 Methodology
- 14.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Antibody Based Therapeutics. Industry analysis & Market Report on Antibody Based Therapeutics is a syndicated market report, published as Global Antibody Based Therapeutics Market 2023 by Company, Regions, Type and Application, Forecast to 2029. It is complete Research Study and Industry Analysis of Antibody Based Therapeutics market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
